The Effects of ECT and/or iTBS on Olfaction and Cognition in Patients With Depression

Depression Clinical Trial

Official title:

The Effects of Electroconvulsive Therapy (ECT) and/or Intermittent Theta Burst Stimulation (iTBS) on Olfaction and Cognition in Patients With Depression

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02804347
• Other study ID #: 6006093
• Status: Completed
• Phase: N/A
• First received: June 2, 2016
• Last updated: September 1, 2017
• Start date: March 2016
• Est. completion date: July 2017

Study information

• Verified date: September 2017
• Source: Queen's University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The sense of smell and cognition are known to be closely associated with mood and emotional processes. However, despite the clear links between olfaction and cognitive processes with emotional states, research into the role of olfaction, cognition, and mood disorders has so far yielded variable results. This study proposes to investigate the ability to detect and identify odours and assess cognition in a group of patients with unipolar and bipolar depression prior to and after receiving their scheduled electroconvulsive therapy (ECT) or intermittent theta burst stimulation (iTBS) treatments. Olfaction will be evaluated utilizing standard olfactory testing protocols using commercially available kits. Cognition will be evaluated utilizing standard cognitive test protocols in a functional magnetic resonance imaging protocol. The results will potentially shed light on the link between olfaction, cognition and mood disorders.

Description:

The research to date indicates that olfactory sensitivity and cognition are reduced in depressed patients. The data also suggest that higher order cognitive odour evaluation, measured via identification testing, is not altered in depression. Furthermore, research into the effect (if any) of treatment on olfactory performance (sensitivity and identification) has been sparse. Researchers have called for studies that examine olfactory sensitivity prior to psychiatric treatment and post-remission. To the best of our knowledge there has yet to be a study on the effect of electroconvulsive therapy (ECT) or intermittent theta burst stimulation (iTBS) treatments on the olfactory performance of patients with treatment refractory Major Depressive Disorder (MDD) and bipolar depression. ECT has been identified as today's most effective treatment for severe depression due to the remission rates, speed of response, and the completeness of remission. iTBS is a new remittent transcranial magnetic stimulation (rTMS) protocol that has gained more notoriety within the field for the speed of administration, effectiveness of the treatment, and speed of response. Unlike rTMS, TBS mimics the endogenous theta rhythms of the brain, which results in greater potency in inducing long-term potentiation of synaptic connections in the targeted brain regions. iTBS has been shown to be effective in treating mood disturbances, and increasing plasticity and inducing neurogenesis in patients. People with MDD often struggle with cognitive impairments such as decreased executive functioning, attention, concentration, speed of processing, and working memory. The brain areas associated with cognition, such as the prefrontal cortex and hippocampus are negatively affected by depression; studies have shown decreased volume, activity, and disturbed brain connectivity in those two areas. Currently, there is a lack of treatment options for improving cognition in depressed patients. The investigators are focussing on exploring the therapeutic potential of iTBS on cognition.The preliminary evidence from our study will add to scientists' understanding of the short and long term effects of iTBS treatment on the cognitive related areas in the brain through the use of fMRI. The investigators also hope our research will allow psychiatrists to deliver better care to patients with debilitating cognitive impairments associated with depression. Overall, a study examining the olfactory and cognitive performance of patients with treatment resistant MDD and bipolar depression, pre-ECT/iTBS, post-ECT/iTBS, and post-remission would yield valuable insight into the link between olfaction and mood disorders as well as cognition and mood disorders.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 30
• Est. completion date: July 2017
• Est. primary completion date: July 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• Signed Patient Informed Consent

• Patients with MDD (DSM-IV-TR - criteria used) OR Patients with bipolar depression (DSM-IV-TR - criteria used)

• Males or females over 18 years of age

• In-patients or out-patients currently scheduled to receive ECT or rTMS

Exclusion Criteria:

• Patients suffering from other neurological or endocrine disorders known to affect olfactory functioning.

• Patients suffering from a respiratory tract infection or other respiratory disorder known to affect olfactory functioning at investigator's discretion

• Schizophrenia, Schizoaffective or other Psychotic Disorder

• Patients over 65 years of age

• Patients with significant allergies

• Patients with environmental sensitivities (e.g. perfumes)

• Patients with mechanical obstruction of the nasal passages (e.g. deviated septum)

• Patients with congenital anosmia or other previous primary olfactory dysfunction

Related Conditions & MeSH terms

• Depression
• Depressive Disorder

Intervention

Device:
• Cognitive Function Imaging and Battery
Individuals will be placed in the fMRI scanner and complete the NBACK Cognitive Task
• Sniffin Sticks
Using Sniffin Sticks, olfactory functioning will be assessed using three tests: identification, discrimination, and threshold.

Other:
• Cognitive Batteries
Participants will conduct the following cognitive batteries: DSST, TMT A & B, RAVLT

Locations

Country	Name	City	State
n/a

Sponsors (2)

Lead Sponsor	Collaborator
Queen's University	Providence HealthCare

References & Publications (33)

Albrecht J, Wiesmann M. [The human olfactory system. Anatomy and physiology]. Nervenarzt. 2006 Aug;77(8):931-9. Review. German. — View Citation

Amsterdam JD, Settle RG, Doty RL, Abelman E, Winokur A. Taste and smell perception in depression. Biol Psychiatry. 1987 Dec;22(12):1481-5. — View Citation

Austin MP, Mitchell P, Goodwin GM. Cognitive deficits in depression: possible implications for functional neuropathology. Br J Psychiatry. 2001 Mar;178:200-6. Review. — View Citation

Berendse HW, Ponsen MM. Detection of preclinical Parkinson's disease along the olfactory trac(t). J Neural Transm Suppl. 2006;(70):321-5. Review. — View Citation

Brand G, Millot JL, Henquell D. Complexity of olfactory lateralization processes revealed by functional imaging: a review. Neurosci Biobehav Rev. 2001 Mar;25(2):159-66. Review. — View Citation

Castaneda AE, Tuulio-Henriksson A, Marttunen M, Suvisaari J, Lönnqvist J. A review on cognitive impairments in depressive and anxiety disorders with a focus on young adults. J Affect Disord. 2008 Feb;106(1-2):1-27. Epub 2007 Aug 20. Review. — View Citation

Doty RL, Shaman P, Dann M. Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. Physiol Behav. 1984 Mar;32(3):489-502. — View Citation

Drevets WC. Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression. Prog Brain Res. 2000;126:413-31. Review. — View Citation

Frodl T, Meisenzahl EM, Zetzsche T, Born C, Groll C, Jäger M, Leinsinger G, Bottlender R, Hahn K, Möller HJ. Hippocampal changes in patients with a first episode of major depression. Am J Psychiatry. 2002 Jul;159(7):1112-8. — View Citation

Fung PK, Robinson PA. Neural field theory of synaptic metaplasticity with applications to theta burst stimulation. J Theor Biol. 2014 Jan 7;340:164-76. doi: 10.1016/j.jtbi.2013.09.021. Epub 2013 Sep 21. — View Citation

Gentner R, Wankerl K, Reinsberger C, Zeller D, Classen J. Depression of human corticospinal excitability induced by magnetic theta-burst stimulation: evidence of rapid polarity-reversing metaplasticity. Cereb Cortex. 2008 Sep;18(9):2046-53. doi: 10.1093/cercor/bhm239. Epub 2007 Dec 28. — View Citation

Golinkoff M, Sweeney JA. Cognitive impairments in depression. J Affect Disord. 1989 Sep-Oct;17(2):105-12. — View Citation

Gross-Isseroff R, Luca-Haimovici K, Sasson Y, Kindler S, Kotler M, Zohar J. Olfactory sensitivity in major depressive disorder and obsessive compulsive disorder. Biol Psychiatry. 1994 May 15;35(10):798-802. — View Citation

Hawkes C. Olfaction in neurodegenerative disorder. Mov Disord. 2003 Apr;18(4):364-72. Review. — View Citation

Kellner CH, Fink M. The efficacy of ECT and "treatment resistance". J ECT. 2002 Mar;18(1):1-2. — View Citation

Lombion-Pouthier S, Vandel P, Nezelof S, Haffen E, Millot JL. Odor perception in patients with mood disorders. J Affect Disord. 2006 Feb;90(2-3):187-91. Epub 2005 Dec 27. — View Citation

Ludvigson, H.W., & Rottman, T.R. (1989). Effects of ambient odours of lavender and cloves on cognition, memory, affect, and mood. Chemical Senses, 14(4), 525-536.

Martzke JS, Kopala LC, Good KP. Olfactory dysfunction in neuropsychiatric disorders: review and methodological considerations. Biol Psychiatry. 1997 Oct 15;42(8):721-32. Review. — View Citation

Negoias S, Croy I, Gerber J, Puschmann S, Petrowski K, Joraschky P, Hummel T. Reduced olfactory bulb volume and olfactory sensitivity in patients with acute major depression. Neuroscience. 2010 Aug 11;169(1):415-21. doi: 10.1016/j.neuroscience.2010.05.012. Epub 2010 May 13. — View Citation

Pause BM, Miranda A, Göder R, Aldenhoff JB, Ferstl R. Reduced olfactory performance in patients with major depression. J Psychiatr Res. 2001 Sep-Oct;35(5):271-7. — View Citation

Plewnia C, Pasqualetti P, Große S, Schlipf S, Wasserka B, Zwissler B, Fallgatter A. Treatment of major depression with bilateral theta burst stimulation: a randomized controlled pilot trial. J Affect Disord. 2014 Mar;156:219-23. doi: 10.1016/j.jad.2013.12.025. Epub 2013 Dec 28. — View Citation

Rolls ET, Kringelbach ML, de Araujo IE. Different representations of pleasant and unpleasant odours in the human brain. Eur J Neurosci. 2003 Aug;18(3):695-703. — View Citation

Satoh S, Morita N, Matsuzaki I, Konishi T, Nakano T, Minoshita S, Arizono H, Saito S, Ayabe AS. Relationship between odor perception and depression in the Japanese elderly. Psychiatry Clin Neurosci. 1996 Oct;50(5):271-5. — View Citation

Seo HS, Jeon KJ, Hummel T, Min BC. Influences of olfactory impairment on depression, cognitive performance, and quality of life in Korean elderly. Eur Arch Otorhinolaryngol. 2009 Nov;266(11):1739-45. doi: 10.1007/s00405-009-1001-0. Epub 2009 Jun 2. — View Citation

Serby M, Larson P, Kalkstein D. Olfactory sense in psychoses. Biol Psychiatry. 1990 Nov 1;28(9):830. — View Citation

Small DM, Jones-Gotman M, Zatorre RJ, Petrides M, Evans AC. Flavor processing: more than the sum of its parts. Neuroreport. 1997 Dec 22;8(18):3913-7. — View Citation

Snaith RP, Hamilton M, Morley S, Humayan A, Hargreaves D, Trigwell P. A scale for the assessment of hedonic tone the Snaith-Hamilton Pleasure Scale. Br J Psychiatry. 1995 Jul;167(1):99-103. — View Citation

Steiner JE, Lidar-Lifschitz D, Perl E. Taste and odor: reactivity in depressive disorders, a multidisciplinary approach. Percept Mot Skills. 1993 Dec;77(3 Pt 2):1331-46. — View Citation

Swiecicki L, Zatorski P, Bzinkowska D, Sienkiewicz-Jarosz H, Szyndler J, Scinska A. Gustatory and olfactory function in patients with unipolar and bipolar depression. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Aug 1;33(5):827-34. doi: 10.1016/j.pnpbp.2009.03.030. Epub 2009 Apr 5. — View Citation

Van Toller S, Reed MK. Brain electrical activity topographical maps produced in response to olfactory and chemosensory stimulation. Psychiatry Res. 1989 Sep;29(3):429-30. — View Citation

Warner MD, Peabody CA, Csernansky JG. Olfactory functioning in schizophrenia and depression. Biol Psychiatry. 1990 Feb 15;27(4):457-8. — View Citation

Weismann M, Yousry I, Heuberger E, Nolte A, Ilmberger J, Kobal G, Yousry TA, Kettenmann B, Naidich TP. Functional magnetic resonance imaging of human olfaction. Neuroimaging Clin N Am. 2001 May;11(2):237-50, viii. — View Citation

Wiesmann M, Kopietz R, Albrecht J, Linn J, Reime U, Kara E, Pollatos O, Sakar V, Anzinger A, Fesl G, Brückmann H, Kobal G, Stephan T. Eye closure in darkness animates olfactory and gustatory cortical areas. Neuroimage. 2006 Aug 1;32(1):293-300. Epub 2006 May 2. — View Citation

* Note: There are 33 references in all — Click here to view all references

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Olfactory Function Change using Burghart's Sniffin' Sticks		Baseline and 6 weeks
Primary	Cognitive Function Change using NBACK, Shopping List, and Symbol Span Tests		Baseline, 6 weeks, 3 months
Secondary	Participant's Olfactory Identification using Sniffin' Sticks Identification Test		Baseline and 6 weeks
Secondary	Participant's Olfactory Threshold using Sniffin' Sticks Threshold Test		Baseline and 6 weeks
Secondary	Participant's Olfactory Discrimination using Sniffin' Sticks DiscriminationTest		Baseline and 6 weeks